1841 CERM,
1841CERM,
2-(3-trifluoromethyl)phenyltetrahydro-1,4- oxazine,
CERM 1841,
CERM-1841,
Flumexadol,
30914-89-7,
2-(3-(Trifluoromethyl)phenyl)morpholine,
2-[3-(trifluoromethyl)phenyl]morpholine,
Flumexadol [INN],
CERM-1841,
Flumexadolum [INN-Latin],
1841 Cerm,
1841CERM,
BRN 1215543,
2-(alpha,alpha,alpha-Trifluoro-m-tolyl)morpholine,
Tetrahydro-2-(alpha,alpha,alpha-trifluoro-m-tolyl)-1,4-oxazine,
(R)-2-(3-(Trifluoromethyl)phenyl)morpholine,
Flumexadolum,
1,4-Oxazine, tetrahydro-2-(alpha,alpha,alpha-trifluoro-m-tolyl)-,
2-(3-trifluoromethyl-phenyl)-morpholine,
1598383-18-6,
AC1L23XN,
CHEMBL578767,
SCHEMBL2109440,
GXPYCYWPUGKQIJ-UHFFFAOYSA-N,
MFCD00864259,
AKOS009358700,
MCULE-3565397097,
NE11727,
BS-14068,
LS-99968,
LS-193684,
SR-01000945260,
2-(3-Trifluoromethyl)phenyltetrahydro-1,4- oxazine,
SR-01000945260-1,
F8880-8284,
Z1318513963,
UNII-V9783UEL0F,
C11H12F3NO,
V9783UEL0F,
CID65774,
C11-H12-F3-N-O,
Morpholine, 2-[3-(trifluoromethyl)phenyl]-,